Table 5 Cost of healthcare resources used
From: Real-life cost-effectiveness of benralizumab in patients with severe asthma
Resources | Cost per patient, mean (SD) | p (Wilcoxon test) | |
|---|---|---|---|
Previous 12 months (baseline) | At 12 months on benralizumab | ||
Diagnosis and complementary tests | 962.71 (44.87) | 218.62 (43.84) | < 0.001 |
Corticosteroids | |||
Oral | 60.79 (32.97) | 4.54 (9.40) | < 0.001 |
Inhaled | 183.44 (89.62) | 105.62 (50.23) | < 0.001 |
Emergency Department visits | 1585.94 (1003.78) | 267.29 (596.48) | < 0.001 |
Admissions | 1599.33 (2937.06) | 615.13 (2601.51) | 0.003 |
Biological treatment for asthma | 7151.63 (7778) | 12,832.04 (2020.17) | < 0.001 |
Total, cost per patient | 11,544 (9137) | 14,043 (3822) | 0.006 |